Wall Street analysts expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to report $759.62 million in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Acadia Healthcare’s earnings. The lowest sales estimate is $713.48 million and the highest is $775.50 million. Acadia Healthcare posted sales of $742.24 million in the same quarter last year, which would indicate a positive year over year growth rate of 2.3%. The firm is expected to report its next earnings results on Tuesday, May 7th.

According to Zacks, analysts expect that Acadia Healthcare will report full year sales of $3.17 billion for the current year, with estimates ranging from $3.12 billion to $3.20 billion. For the next year, analysts forecast that the firm will report sales of $3.35 billion, with estimates ranging from $3.27 billion to $3.39 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that cover Acadia Healthcare.

A number of research analysts have recently commented on ACHC shares. BidaskClub upgraded Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Friday, January 11th. TheStreet downgraded Acadia Healthcare from a “c” rating to a “d” rating in a research report on Friday, March 1st. Deutsche Bank started coverage on Acadia Healthcare in a research report on Thursday, January 3rd. They set a “hold” rating and a $27.00 target price for the company. Robert W. Baird lowered their target price on Acadia Healthcare from $40.00 to $38.00 and set a “neutral” rating for the company in a research report on Monday, March 4th. Finally, Mizuho set a $30.00 target price on Acadia Healthcare and gave the company a “hold” rating in a research report on Friday, January 25th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $37.20.

Shares of NASDAQ ACHC traded down $0.61 during midday trading on Thursday, reaching $29.30. 499,500 shares of the stock traded hands, compared to its average volume of 1,098,694. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.08 and a current ratio of 1.08. The company has a market capitalization of $2.66 billion, a P/E ratio of 13.08, a P/E/G ratio of 1.70 and a beta of 0.67. Acadia Healthcare has a one year low of $24.27 and a one year high of $45.35.

A number of large investors have recently added to or reduced their stakes in the stock. Oregon Public Employees Retirement Fund lifted its stake in shares of Acadia Healthcare by 2,686.1% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 897,973 shares of the company’s stock valued at $35,000 after purchasing an additional 865,743 shares during the last quarter. Advisor Group Inc. lifted its stake in shares of Acadia Healthcare by 23.9% in the 4th quarter. Advisor Group Inc. now owns 3,039 shares of the company’s stock valued at $78,000 after purchasing an additional 587 shares during the last quarter. Pearl River Capital LLC acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $92,000. Ffcm LLC raised its holdings in shares of Acadia Healthcare by 183.6% in the 4th quarter. Ffcm LLC now owns 4,697 shares of the company’s stock valued at $121,000 after buying an additional 3,041 shares during the period. Finally, NumerixS Investment Technologies Inc purchased a new stake in shares of Acadia Healthcare in the 4th quarter valued at $156,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Further Reading: How accurate is the Rule of 72?

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.